Published on 23 Oct 2023 on Simply Wall St. via Yahoo Finance
Arcus Biosciences' (NYSE:RCUS) investors will be pleased with their notable 66% return over the last...
Arcus Biosciences, Inc. (NYSE:RCUS) shareholders might be concerned after seeing the share price drop 18% in the last month. But the silver lining is the stock is up over five years. In that time, it is up 66%, which isn't bad, but is below the market return of 69%. While the long term returns are impressive, we do have some sympathy for those who bought more recently, given the 42% drop, in the last year.
Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.
Check out our latest analysis for Arcus Biosciences